An End-to-End Synthetic Oncology Clinical Trial Framework Integrating Radiographic Response, Circulating Tumor DNA, Safety, and Survival for Decision-Oriented Clinical Data Science
This study presents a comprehensive, literature-informed synthetic phase II oncology clinical trial framework that successfully integrates radiographic, molecular (ctDNA), safety, and survival data to generate a biologically plausible, analytically coherent efficacy-safety signal, thereby serving as a decision-oriented prototype for translational clinical data science.